Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-24

Clinical Trial Results: Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fexuprazan to esomeprazole in gastroesophageal reflux disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole (Esomeprazole)
  • Fexuprazan (fexuprazan)

Snippet

Sponsor: Indonesia University | Conditions: Gastro Oesophageal Reflux Disease | Phase 3 | Status: COMPLETED | Results posted: 2026-08-24